Back

Axl improves cardiac microvascular injury via mitochondrial Ca2+ and Fe2+ homeostasis in cardiac ischemia-reperfusion injury

30 August 2026 (17:15 - 17:45)
Organised by: Logo
Congress Presentation Part of: Ischaemia-reperfusion injury: new biological mechanisms of repair Reperfusion and Reperfusion Injury ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Youran Li

Zhongshan Hospital, Shanghai (China)

4 More presentations in this session

Presentation thumbnail
Increased interleukin-6 levels associate with worse 1-year outcome after acute myocardial infarction and link infarct size, impaired iron status and heart failure
Doctor M. Matter (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
LRP3 promotes angiogenesis after ischemia and affects the survival and prognosis of patients with myocardial infarction.
Doctor C. Zhai (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Fat attenuation index and plaque characteristics on coronary computed tomography angiography correlation with high-risk plaques identified by optical coherence tomography
Doctor L. Guo (Dalian, CN)
Abstract Slides Video
Presentation thumbnail
Cardioprotection by soluble urokinase plasminogen activator receptor (suPAR) in an in vivo model of myocardial infarction with ischaemia-reperfusion
Doctor J. Chew-Harris (Christchurch, NZ)
Abstract Slides

Access the full session

Session thumbnail
Ischaemia-reperfusion injury: new biological mechanisms of repair

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Session
Novel targets against myocardial damage
30 August 2024
thumbnail
Congress Presentation
Genetically determined cardio-inflammatory phenotypes in recurrent pericarditis: a systematic review and meta-analysis
30 August 2026
thumbnail
Congress Presentation
Atrial fibrillation and coronary microvascular dysfunction - A Clinical Signal
29 August 2026
thumbnail
Congress Presentation
Targeting fibroblast CTHRC1 ameliorates cardiac fibrosis and dysfunction by suppressing cardiomyocyte NLRP3 inflammasome activation
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources